<SEC-DOCUMENT>0001019056-20-000644-index.html : 20201218 <SEC-HEADER>0001019056-20-000644.hdr.sgml : 20201218 <ACCEPTANCE-DATETIME>20201217190916 ACCESSION NUMBER: 0001019056-20-000644 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20201218 DATE AS OF CHANGE: 20201217 GROUP MEMBERS: ROSALIND ADVISORS, INC. GROUP MEMBERS: ROSALIND MASTER FUND L.P. GROUP MEMBERS: STEVEN SALAMON SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PLx Pharma Inc. CENTRAL INDEX KEY: 0001497504 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271707962 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-88072 FILM NUMBER: 201397544 BUSINESS ADDRESS: STREET 1: 9 FISHERS LANE STREET 2: SUITE E CITY: SPARTA STATE: NJ ZIP: 07871 BUSINESS PHONE: (713) 842-1249 MAIL ADDRESS: STREET 1: 9 FISHERS LANE STREET 2: SUITE E CITY: SPARTA STATE: NJ ZIP: 07871 FORMER COMPANY: FORMER CONFORMED NAME: Dipexium Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20140313 FORMER COMPANY: FORMER CONFORMED NAME: Dipexium Pharmaceuticals, LLC DATE OF NAME CHANGE: 20100726 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Rosalind Advisors, Inc. CENTRAL INDEX KEY: 0001622627 IRS NUMBER: 000000000 FISCAL YEAR END: 1130 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 175 BLOOR STREET EAST STREET 2: SUITE 1316, NORTH TOWER CITY: TORONTO STATE: A6 ZIP: M4W 3R8 BUSINESS PHONE: 4168887606 MAIL ADDRESS: STREET 1: 175 BLOOR STREET EAST STREET 2: SUITE 1316, NORTH TOWER CITY: TORONTO STATE: A6 ZIP: M4W 3R8 </SEC-HEADER> <DOCUMENT> <TYPE>SC 13G <SEQUENCE>1 <FILENAME>plxpharma_13g.htm <DESCRIPTION>SC 13G <TEXT> Document 1 - file: plxpharma_13g.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.A <SEQUENCE>2 <FILENAME>ex_a.htm <DESCRIPTION>EXHIBIT A <TEXT> Document 2 - file: ex_a.htm
</DOCUMENT> </SEC-DOCUMENT>